KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Liabilities (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Total Liabilities readings, the most recent being $31.8 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 1.05% to $31.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $31.8 billion, a 1.05% decrease, with the full-year FY2025 number at $32.8 billion, down 2.3% from a year prior.
  • Total Liabilities hit $31.8 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $32.8 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $36.8 billion in Q1 2022 to a low of $31.8 billion in Q1 2026.
  • Median Total Liabilities over the past 5 years was $34.8 billion (2024), compared with a mean of $34.4 billion.
  • Biggest five-year swings in Total Liabilities: rose 1.92% in 2024 and later decreased 8.75% in 2025.
  • Teva Pharmaceutical Industries' Total Liabilities stood at $35.4 billion in 2022, then decreased by 0.17% to $35.4 billion in 2023, then dropped by 4.94% to $33.6 billion in 2024, then dropped by 2.3% to $32.8 billion in 2025, then fell by 3.12% to $31.8 billion in 2026.
  • The last three reported values for Total Liabilities were $31.8 billion (Q1 2026), $32.8 billion (Q4 2025), and $32.6 billion (Q3 2025) per Business Quant data.